Skip to content
drillr.ai
Sign up

A

AGILENT TECHNOLOGIES, INC.

NYSE · Healthcare · Medical - Diagnostics & Research · US

$150.84
+0.57%
Ask drillr

  • Sep 4, 2026, 12:00 UTC

    Agilent Technologies launched the Agilent S540MD Slide Scanner System in the U.S. after receiving FDA clearance, expanding its digital pathology portfolio.

    Source:

  • Aug 26, 2026, 23:59 UTC

    Agilent Technologies reported Q3 2026 revenue of $1.88 billion, growing 7.3% on a core basis, and issued FY2026 guidance.

    Source:

  • Aug 26, 2026, 00:00 UTC

    Agilent Technologies reported Q3 2026 revenue of $1.878 billion, up 8.1% year-over-year, with net income of $362 million and diluted EPS of $1.28.

    Source:

  • Aug 23, 2026, 08:29 UTC

    EP Wealth Advisors LLC acquired a new stake of 11,685 shares in Agilent Technologies, Inc. during the second quarter, as disclosed in its Form 13F filing with the SEC.

    Source:

  • Aug 22, 2026, 07:07 UTC

    Allworth Financial LP disclosed a new minority stake in Agilent Technologies, Inc. by purchasing 20,420 shares worth approximately $2.71 million during the second quarter, as reported in its 13F filing.

    Source:

  • Aug 21, 2026, 09:35 UTC

    Advisors Capital Management LLC purchased a new position in Agilent Technologies, Inc. (NYSE: A) during the undefined quarter, acquiring 62,474 shares valued at approximately $8,299,000, as disclosed in a recent SEC filing.

    Source:

  • Aug 15, 2026, 07:45 UTC

    Assenagon Asset Management S.A. decreased its stake in Agilent Technologies, Inc. by 75.3% during the second quarter, selling 31,934 shares and retaining 10,454 shares, as disclosed in a recent SEC filing.

    Source:

  • Jul 20, 2026, 07:11 UTC

    Agilent Technologies increased its investment in HALO X-ray Technologies with a multimillion dollar investment round to enable HALO to complete regulatory approval of its advanced security screening technology.

    Source:

  • Jul 8, 2026, 12:00 UTC

    Agilent Technologies Inc. announced the expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns for biotherapeutic analysis.

    Source:

  • Jul 1, 2026, 12:00 UTC

    Agilent Technologies launched the Agilent xCELLigence RTCA eSight AI, an AI-powered software module for label-free imaging analysis.

    Source:

  • Jun 25, 2026, 12:00 UTC

    Agilent Technologies completed its acquisition of Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners LLP.

    Source:

  • Jun 25, 2026, 00:00 UTC

    Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corp, effective July 1, 2026.

  • Jun 25, 2026, 00:00 UTC

    Agilent Technologies issued $600 million of 4.900% Senior Notes due 2032 in a private placement that closed on June 25, 2026.

  • Jun 3, 2026, 11:00 UTC

    Agilent Technologies announced a collaboration with OpenAI and Boston Consulting Group to accelerate AI-driven scientific innovation.

    Source:

  • Jun 2, 2026, 20:15 UTC

    The U.S. FDA approved the expanded use of Agilent's PD-L1 IHC 22C3 pharmDx on the Dako Omnis platform for identifying patients with esophageal squamous cell carcinoma, triple-negative breast cancer, cervical cancer, and gastric or gastroesophageal junction adenocarcinoma.

    Source:

  • Jun 1, 2026, 12:01 UTC

    Agilent reported Q2 earnings that beat estimates and raised its fiscal 2026 outlook.

    Source: